COVID‐SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults

BACKGROUND/OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection causes high morbidity and mortality in older adults with chronic illnesses. Several trials are currently underway evaluating the antimalarial drug hydroxychloroquine as a potential treatment for acute infec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Am Geriatr Soc
Main Authors: Ross, Sydney B., Wilson, Marnie Goodwin, Papillon‐Ferland, Louise, Elsayed, Sarah, Wu, Peter E., Battu, Kiran, Porter, Sandra, Rashidi, Babak, Tamblyn, Robyn, Pilote, Louise, Downar, James, Bonnici, Andre, Huang, Allen, Lee, Todd C., McDonald, Emily G.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
COVID‐19‐Related Content
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280600/
https://ncbi.nlm.nih.gov/pubmed/32441771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.16623
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares